Marc Lang
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Synthesis and biological activity, HER2/EGFR in Cancer Research, PI3K/AKT/mTOR signaling in cancer, Ubiquitin and proteasome pathways
Most-Cited Works
- → New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis(2000)213 cited
- → Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines(1997)205 cited
- → New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development(1998)199 cited
- → Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805(2010)119 cited
- → Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability(1996)78 cited
- → Entry into a new class of protein kinase inhibitors by pseudo ring design(2008)67 cited
- → Entry into a New Class of Potent Proteasome Inhibitors Having High Antiproliferative Activity by Structure-Based Design(2004)55 cited
- → Modeling of the Binding Mode of a Non-covalent Inhibitor of the 20S Proteasome. Application to Structure-Based Analogue Design(2001)29 cited
- → Usefulness of Antiplatelet Drugs in the Management of Heparin-Associated Thrombocytopenia and Thrombosis(1991)24 cited
- → New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis.(2000)23 cited